
Anti-Bim(IN)Antibody
CatalogNo.:2414
Size:100ugIgGinPBS,pH7.4,purifiedbyimmunoaffinitychromatography.
BACKGROUND
AnovelBH3domain-containingproteinwasrecentlyidentifiedanddesignatedBimorBODfromhuman,mouse,andrat.Bim/BODinteractswithdiversemembersinthepro-survivalBcl-2subfamilyincludingBcl-2,Bcl-xL,andBcl-w.Bim/BODinducesapoptosis.ThemessengerRNAofBimisubiquitouslyexpressedinmultipletissuesandcelllines.
Antigen:Peptidecorrespondingtoaa22-40ofhumanBim.Thesequenceisidenticaltothatofmouseandisdifferentbyoneaminoacidfromthatofrat.
HostSpecies:Rabbit
StABIlizers:None
Preservatives:0.02%sodiumazide.
Thisantibodyrecognizesfull-lengthBim(23kDa)ofhuman,mouse,andrat.
Forinvitroinvestigationaluseonly.Notforuseintherapeuticordiagnosticprocedures.
APPLICATIONSImmunoblotting:useat1ug/ml.
WesternblotanalysisofBiminK562(K)andA549(A)wholecelllysateswithBimantibodyat1μg/ml.
Immunocytochemistry:usea10-20ug/ml
ImmunohistochemicalstainingofBiminhumanskincancercellswithBimantibodyat20μg/ml.
Thesearerecommendedconcentrations.Endusershoulddetermineoptimalconcentrationfortheirapplication.
Positivecontrol:WholecelllysateofhumanK562cells.
DiluteinPBSormediumwhichisidenticaltothatusedintheassaysystem.
Thisantibodyisstableforatleastone(1)yearat-20oC.Avoidmultiplefreeze-thawcycles.